Wang et al. designed a T7-modified nanomedicine capable of crossing the intact BBB in a mouse model and targeting delivery in intracranial gliomas, utilizing transferrin’s natural binding properties for efficient accumulation in brain tumor regions [189]. Here, TF is linked to brain neoplasm.